• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-29通过靶向p85α和细胞分裂周期蛋白42激活p53。

miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

作者信息

Park Seong-Yeon, Lee Jung Hyun, Ha Minju, Nam Jin-Wu, Kim V Narry

机构信息

National Creative Research Center and School of Biological Sciences, Seoul National University, 599 Gwanangno, Gwanak-gu, Seoul 151-742, South Korea.

出版信息

Nat Struct Mol Biol. 2009 Jan;16(1):23-9. doi: 10.1038/nsmb.1533. Epub 2008 Dec 14.

DOI:10.1038/nsmb.1533
PMID:19079265
Abstract

The tumor suppressor p53 is central to many cellular stress responses. Although numerous protein factors that control p53 have been identified, the role of microRNAs (miRNAs) in regulating p53 remains unexplored. In a screen for miRNAs that modulate p53 activity, we find that miR-29 family members (miR-29a, miR-29b and miR-29c) upregulate p53 levels and induce apoptosis in a p53-dependent manner. We further find that miR-29 family members directly suppress p85 alpha (the regulatory subunit of PI3 kinase) and CDC42 (a Rho family GTPase), both of which negatively regulate p53. Our findings provide new insights into the role of miRNAs in the p53 pathway.

摘要

肿瘤抑制因子p53在许多细胞应激反应中起核心作用。尽管已经鉴定出许多控制p53的蛋白质因子,但微小RNA(miRNA)在调节p53中的作用仍未被探索。在一项筛选调节p53活性的miRNA的研究中,我们发现miR-29家族成员(miR-29a、miR-29b和miR-29c)以上调p53水平并以p53依赖的方式诱导细胞凋亡。我们进一步发现,miR-29家族成员直接抑制p85α(PI3激酶的调节亚基)和CDC42(一种Rho家族GTP酶),这两者均对p53起负调节作用。我们的研究结果为miRNA在p53途径中的作用提供了新的见解。

相似文献

1
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.微小RNA-29通过靶向p85α和细胞分裂周期蛋白42激活p53。
Nat Struct Mol Biol. 2009 Jan;16(1):23-9. doi: 10.1038/nsmb.1533. Epub 2008 Dec 14.
2
miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.miR-185 靶向 RhoA 和 Cdc42 的表达并抑制人结直肠细胞的增殖潜能。
Cancer Lett. 2011 Feb 28;301(2):151-60. doi: 10.1016/j.canlet.2010.11.009. Epub 2010 Dec 24.
3
MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.miR-29a 通过靶向 CDC42/PAK1 信号通路抑制宫颈癌中的细胞增殖和迁移。
Anticancer Drugs. 2019 Jul;30(6):579-587. doi: 10.1097/CAD.0000000000000743.
4
miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells.miR-137 靶向 Cdc42 的表达,诱导结直肠癌细胞周期 G1 期阻滞并抑制其侵袭。
Int J Cancer. 2011 Mar 15;128(6):1269-79. doi: 10.1002/ijc.25452.
5
miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.miR-148b-3p 通过抑制 Dock6/Rac1/Cdc42 轴抑制胃癌转移。
J Exp Clin Cancer Res. 2018 Mar 27;37(1):71. doi: 10.1186/s13046-018-0729-z.
6
p53 mediates bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway.p53通过激活Cdc42/JNK1信号通路介导bcl-2磷酸化和细胞凋亡。
Oncogene. 2000 Nov 2;19(46):5259-69. doi: 10.1038/sj.onc.1203895.
7
miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients.miR-29a/b/c通过靶向CDC42发挥胶质瘤侵袭抑制因子的作用,并可预测患者的预后。
Br J Cancer. 2017 Sep 26;117(7):1036-1047. doi: 10.1038/bjc.2017.255. Epub 2017 Aug 8.
8
The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.靶向PTTG1的微小RNA miR-329、miR-300、miR-381和miR-655可抑制垂体肿瘤细胞的肿瘤发生,并参与p53/PTTG1调节反馈回路。
Oncotarget. 2015 Oct 6;6(30):29413-27. doi: 10.18632/oncotarget.5003.
9
miR-18a inhibits CDC42 and plays a tumour suppressor role in colorectal cancer cells.微小RNA-18a抑制细胞分裂周期蛋白42,并在结肠癌细胞中发挥肿瘤抑制作用。
PLoS One. 2014 Nov 7;9(11):e112288. doi: 10.1371/journal.pone.0112288. eCollection 2014.
10
miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42.miR-330 通过靶向 Cdc42 调节结直肠癌细胞的增殖。
Biochem Biophys Res Commun. 2013 Feb 15;431(3):560-5. doi: 10.1016/j.bbrc.2013.01.016. Epub 2013 Jan 18.

引用本文的文献

1
Improved wound healing by dual inhibition of miR-146a-5p and miR-29a-3p supports a network action of dysregulated miRNAs in diabetic skin.通过双重抑制miR-146a-5p和miR-29a-3p改善伤口愈合,支持糖尿病皮肤中失调的微小RNA的网络作用。
Diabetologia. 2025 Sep 3. doi: 10.1007/s00125-025-06522-3.
2
Cancer-Associated Genetic Aberrations and Precision Medicine.癌症相关的基因畸变与精准医学
Int J Med Sci. 2025 Jun 12;22(12):2932-2943. doi: 10.7150/ijms.109506. eCollection 2025.
3
Expression of some circulating microRNAs as predictive biomarkers for prognosis and treatment response in glioblastoma.

本文引用的文献

1
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.骨骼肌生成和横纹肌肉瘤中的NF-κB-YY1-miR-29调控回路
Cancer Cell. 2008 Nov 4;14(5):369-81. doi: 10.1016/j.ccr.2008.10.006.
2
MicroRNAs in cancer.癌症中的微小RNA
Annu Rev Pathol. 2009;4:199-227. doi: 10.1146/annurev.pathol.4.110807.092222.
3
A complex barcode underlies the heterogeneous response of p53 to stress.一个复杂的条形码构成了p53对压力的异质性反应的基础。
某些循环微RNA作为胶质母细胞瘤预后和治疗反应预测生物标志物的表达
Sci Rep. 2025 Jan 14;15(1):1933. doi: 10.1038/s41598-024-83800-x.
4
Natural compounds targeting miRNAs: a novel approach in oral cancer therapy.靶向 miRNA 的天然化合物:口腔癌治疗的新方法。
Funct Integr Genomics. 2024 Oct 25;24(6):202. doi: 10.1007/s10142-024-01473-1.
5
The Role of MicroRNAs in HIV Infection.微小 RNA 在人类免疫缺陷病毒感染中的作用。
Genes (Basel). 2024 Apr 29;15(5):574. doi: 10.3390/genes15050574.
6
The role of CEMIP in cancers and its transcriptional and post-transcriptional regulation.CEMIP 在癌症中的作用及其转录和转录后调控。
PeerJ. 2024 Feb 19;12:e16930. doi: 10.7717/peerj.16930. eCollection 2024.
7
Mesenchymal stem cells-derived extracellular vesicle-incorporated H19 attenuates cardiac remodeling in rats with heart failure.间质干细胞衍生的细胞外囊泡包裹的 H19 减轻心力衰竭大鼠的心脏重构。
Kaohsiung J Med Sci. 2024 Jan;40(1):46-62. doi: 10.1002/kjm2.12774. Epub 2023 Oct 27.
8
Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt's lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib.克服EZH2抑制剂在伯基特淋巴瘤中的治疗局限性:MS1943与依鲁替尼联合效应的综合研究
Front Oncol. 2023 Sep 11;13:1252658. doi: 10.3389/fonc.2023.1252658. eCollection 2023.
9
Common microRNA regulated pathways in Alzheimer's and Parkinson's disease.阿尔茨海默病和帕金森病中常见的微小RNA调控通路。
Front Neurosci. 2023 Sep 1;17:1228927. doi: 10.3389/fnins.2023.1228927. eCollection 2023.
10
LncRNA WEE2-AS1 knockdown inhibits the proliferation, migration and invasion of glioma cells via regulating miR-29b-2-5p/TPM3 axis.LncRNA WEE2-AS1 敲低通过调控 miR-29b-2-5p/TPM3 轴抑制胶质瘤细胞的增殖、迁移和侵袭。
Oncol Res. 2022 Jul 13;29(2):105-117. doi: 10.32604/or.2022.03536. eCollection 2021.
Nat Rev Mol Cell Biol. 2008 Sep;9(9):702-12. doi: 10.1038/nrm2451.
4
Targeting p53 to mitochondria for cancer therapy.将p53靶向线粒体用于癌症治疗。
Cell Cycle. 2008 Jul 1;7(13):1949-55. doi: 10.4161/cc.7.13.6222.
5
MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins.微小RNA 29c在鼻咽癌中表达下调,可上调编码细胞外基质蛋白的信使核糖核酸。
Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5874-8. doi: 10.1073/pnas.0801130105. Epub 2008 Apr 4.
6
P53 promoter selection: choosing between life and death.P53启动子的选择:在生与死之间抉择。
Cell Cycle. 2008 Jan 15;7(2):154-7. doi: 10.4161/cc.7.2.5236. Epub 2007 Oct 22.
7
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.微小RNA miR-373和miR-520c促进肿瘤侵袭和转移。
Nat Cell Biol. 2008 Feb;10(2):202-10. doi: 10.1038/ncb1681. Epub 2008 Jan 13.
8
Rho GTPases: functions and association with cancer.Rho GTP酶:功能及其与癌症的关联
Clin Exp Metastasis. 2007;24(8):657-72. doi: 10.1007/s10585-007-9119-1. Epub 2007 Nov 14.
9
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.微小RNA-29家族通过靶向DNA甲基转移酶3A和3B逆转肺癌中的异常甲基化。
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15805-10. doi: 10.1073/pnas.0707628104. Epub 2007 Sep 21.
10
RNA-interference-mediated Cdc42 silencing down-regulates phosphorylation of STAT3 and suppresses growth in human bladder-cancer cells.
Biotechnol Appl Biochem. 2008 Feb;49(Pt 2):121-8. doi: 10.1042/BA20070107.